Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-20

Clinical Trial Update: The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing how botulinum toxin treatment affects quality of life in patients with cervical dystonia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Roongroj Bhidayasiri | Conditions: Botulinum Toxin, Quality of Life | Phase 4 | Status: UNKNOWN